INTRODUCTION
Bacterial translocation (BT) is the passage of viable bacteria or their products from the intestines to extraintestinal sites (Gatt et al . 2007 ). Trillions of microbes live in the mammalian gastrointestinal tract (GIT), the majority of which reside in the colon (Ley et al . 2008 ) . It is believed that reduced perfusion and impaired oxygen delivery to the GIT results in increased intestinal permeability, leading to translocation of normal intestinal flora (Kellum et al . 2004 ) .
The route of BT has been examined in both humans and animals. A study of human trauma patients (Moore et al . 1991 ) evaluated blood samples from portal vein (PV) catheters for evidence of translocating bacteria or endotoxin. Only 2% of all PV cultures were positive for bacterial growth, and no endotoxin was detected in portal or systemic blood. Rodent models examining the route of translocation suggest that mesenteric lymph is a significant route of BT (MacFie et al . 1999 ) . The incidence of BT in humans undergoing emergency laparotomy has been found to be 14 to 21% when mesenteric lymph node (MLN) cultures were evaluated (MacFie et al . 2006 ) . Veterinary studies examining populations of dogs documented the BT rates of 52% in healthy dogs undergoing ovariohysterectomy from MLN cultures and 19% in dogs with haemorrhagic gastroenteritis (HGE) from PV samples (Dahlinger et al . 1997 , Unterer et al . 2011 .
Methods to document the occurrence of BT have also been an active area of research. Numerous molecules have been evaluated as potential biomarkers for BT, including bacterial DNA, soluble CD14, LPS/endotoxin, lipopolysaccharide binding protein ( LBP), calprotectin and pro-calcitonin (Koutsounas et al . 2015 ) . Each marker has its advantages and disadvantages, and while no single biomarker outperforms the others, further studies are required to fully evaluate their usefulness in diagnosing BT. Bacterial DNA and LPS are microbial components that are associated with a marked inflammatory response in extraintestinal sites, but both have variable rates of detection (Le Roy et al . 2001 , Guarner et al . 2006 . Calprotectin is a calcium-binding protein found in neutrophils, monocytes and macrophages that is resistant to degradation during intestinal transit (von Arnim et al . 2016 ). This may be the most promising biomarker because it was strongly correlated with BT and readily analysed via a faecal assay (Gundling et al . 2011 ) .
There is controversy regarding the clinical relevance of BT and its relationship to gut-derived sepsis because they can occur independently of each other (Deitch 2012 ) . However, there is an established relationship between intestinal dysmotility and bacterial overgrowth that can predispose to BT (Penalva et al . 2004 ) . Stagnant luminal contents along with a devitalised bowel wall can lead to a profound increase in bacteria count, six hours of ileus increases bacterial numbers from 10 2 to 10 4 /mL of ingesta to 10 8 to 10 11 /mL (Radlinsky 2013 ) . While BT is a clinical event that is associated with a higher incidence of septic complications in humans , this relationship has yet to be established in veterinary medicine. A recent retrospective study showed that not all patients with a positive diagnosis of bacteraemia developed septic complications, with an incidence of positive bacterial cultures in 14·9% of dogs and 13·4% of cats (Greiner et al . 2008 ) . Similarly, no difference was noted in the incidence of BT between patients with acute haemorrhagic diarrhoea receiving amoxicillin/clavulanic acid versus placebo, or in the severity of clinical signs, laboratory parameters, length of hospitalisation (LOH) or mortality rates (Unterer et al . 2015 ) .
The main concern associated with BT is the potential for development of septic complications. Sepsis, defined as lifethreatening organ dysfunction caused by a dysregulated host response to infection (Singer et al . 2016 ) , is associated with high mortality rates in veterinary patients ranging from 21 to 57% (Bentley et al . 2007 , Kenney et al . 2010 , Craft & Powell 2012 .
Enteropathogenic bacteria are the source of BT following dysbiosis and compromised barrier function (Brandl & Schnabi 2015 ) . Treatments aimed at limiting BT include restoration of intestinal perfusion, initiating early enteral nutrition (EN), preserving the normal GI flora and protecting GI barrier function (Assalia et al . 2001 , Deitch 2002 , Liu et al . 2012 ).
HOST DEFENCE MECHANISMS
The main defence mechanisms against BT include preventing intestinal dysbiosis and limiting bacterial adherence. Dysbiosis is the shift in the microbiota composition in which there is a decrease in the number of beneficial bacteria (e.g. anaerobes such as Bacteroides and Fusobacterium ) and an increase in potentially pathogenic bacteria (e.g. Enterococcus , Staphylococcus and Escherichia coli ) (Ducatelle et al . 2015 ) . The host and its microflora exist in a symbiotic relationship, conferring many benefits upon the host (Brenchley & Douek 2012 ) . The abundance of normal bacteria (commensal microflora, indigenous microbiota) act against pathogenic bacteria through direct competition for nutrient sources and sites of adherence to the epithelial barrier. Commensals also produce antimicrobial factors including lactic acid, short-chain fatty acids and bacteriocins that limit the growth of pathogenic bacteria (Fagarassan et al . 2002 ) .
Gut-associated lymphoid tissue (GALT) is the largest lymphoid system in the body and consists of the Peyer patches in the small intestine, isolated lymphoid follicles, MLNs and the lamina propria of the mucosa. Within the lamina propria, dendritic cells serve as antigen-presenting cells to the T cells of the MLNs, while macrophages perform bacterial phagocytosis and secrete cytokines to maintain local immunity (Gross et al . 2015 ) . Plasma cells of the lamina propria secrete IgA, which enters the intestinal lumen via transcytosis and limits bacterial adhesion and entry into the epithelium (Allenspach 2011 ) . The epithelial barrier of the GIT itself provides host protection and a physical barrier against BT. Enterocytes are joined together by a series of proteins that create intracellular tight junctions, limiting permeability. The mucus layer consists of an internal water layer, an epithelial surface layer (phospholipids, mucous gel coat and epithelial cells), sub-epithelial connective tissue and the capillary endothelium (Faderl et al . 2015 ) . Coupled with intestinal peristalsis, mucus production limits the ability for bacterial adherence while tight junctions limit paracellular bacterial movement (Yandrapu & Sarosiek 2015 ) .
The liver and the GIT share a close anatomic relationship, with the liver receiving 75% of its blood supply from the PV (Lin et al . 2015 ) . Damage to the GIT epithelium can allow passage of bacteria and endotoxin to the liver via the portal circulation (Tsiaoussis et al . 2015 ) . Endothelial cells in the wall of the liver sinusoids, Kupffer cells in the periportal area and liver-resident lymphocytes clear organisms and microbial products from the portal venous circulation (Jenne & Kubes 2013 ) .
Bile acids (BA), synthesised in the liver, can affect microbiota both directly and indirectly (Nie et al . 2015 ) . Activation of intracellular ligand-activated nuclear receptors, such as the farnesoid X receptor (FXR) results in the regulatory function of BA (Ding et al . 2015 ) . Present in both the liver and intestines, FXR controls BA levels, regulates BA synthesis and enterohepatic flow (Matsubara et al . 2013 ) . FXR activation has been shown to inhibit epithelial permeability and reduce goblet cell loss secondary to chemically induced intestinal inflammation, as well as inhibit pro-inflammatory cytokine production in the colonic mucosa (Gadaleta et al . 2011 ) . BA directly affect bacterial cell membrane integrity by dissolving phospholipids and dissociating intrinsic membrane proteins, causing cytosolic leakage. An indirect effect of BA is the expression of enteroprotective genes via upregulated production of antimicrobial peptides such as cathelicidin. Cathelicidin has a cationic attraction to the anionic surface of the bacterial cell membrane, leading to a curvature strain and disruption of membrane homoeostasis (Wei & Christakos 2015 ) . Finally, BA break down endotoxin into harmless fragments via a detoxifying detergent action on the outer lipoprotein structure (Bertok 2004 ) . Administration of oral BA has been shown to reduce bacterial overgrowth, BT and endotoxaemia (LorenzoZuniga et al . 2003 ) .
PATHOPHYSIOLOGY
BT can be a normal physiologic event without adverse consequences (Dahlinger et al . 1997 ) but can result in systemic illness if there is concomitant splanchnic hypoperfusion and subsequent ischaemia-reperfusion injury (IR), immune dysfunction and increased intestinal mucosal permeability. This is referred to as the "three-hit model" theory of BT (Deitch 2002 ) . Intestinal hypoperfusion leads to the production of pro-inflammatory factors (first hit). Subsequent fluid resuscitation leads to reperfusion and IR injury (second hit), with loss of gut barrier function and an upregulated immune response (third hit).
Events in veterinary patients that may lead to the compromise of mesenteric blood flow and result in BT include gastric-dilatation volvulus, intestinal entrapment, portal hypertension and mesenteric and colonic torsion (Junius et al . 2004 , Buob et al . 2011 , Bruchim et al . 2012 . These conditions lead to shock, which occurs secondary to poor tissue perfusion causing a critical decrease in oxygen delivery so that it is insufficient for tissue demands (Porter et al . 2013 ) . Oxygen tension at the intestinal villous tip is lower than that of the arterial blood. Hypoperfusion causes decreased tissue oxygenation (hypoxia) resulting in mucosal acidosis (Lardner 2001 ) . Acidosis leads to an increased mucosal permeability with the production of reactive oxygen species (ROS), causing detachment of the enterocytes from the basement membrane and apoptosis (Chang et al . 2005 ) . As stores of cellular adenosine triphosphate (ATP) are depleted, the existing ATP is degraded by the hypoxanthine xanthine-oxido-reductase enzyme system with the eventual formation of a hydroxyl radical (McMichael & Moore 2004 ) . ATP-dependent cell membrane pumps are inactivated, resulting in cellular swelling due to an efflux of potassium and an influx of sodium, calcium and chloride. Failure of the Na+/K+ ATPase pump will drive the Na+/Ca2+ exchange pump in reverse, increasing movement of calcium from the sarcoplasmic reticulum and extracellular space into the cytosol (Cassutto & Gfeller 2003 ) . There is also a massive influx of intracellular calcium into the arachidonic acid cascade increasing phospholipase A2 activity and generating further inflammation. The calcium movement from the mitochondria to the cytosol drives further ROS formation by activating calpain, the enzyme that converts xanthine dehydrogenase to xanthine oxidase (Cassutto & Gfeller 2003 ) .
Intestinal ischaemia leads to mucin breakdown, which allows access of pancreatic enzymes to the epithelium and causes increased intestinal permeability . Pancreatic enzymes such as elastase, lipase, trypsin and chymotrypsin can cause cell death and leucocyte activation (Waldo et al . 2003 ) . Even in the absence of ischaemia, mucin disruption increases bowel permeability and in the presence of pancreatic enzymes can induce shock and increase systemic protease activation . Intestinal ischaemia, pancreatic digestive enzymes and bacteria/endotoxin enhance mucosal permeability. Pancreatic duct ligation has been shown to have a limited protective effect in a haemorrhagic shock model (Cohen et al . 2004 ) .
The release of bacteria or endotoxin is recognised by the innate immune system through pattern recognition receptors (PRR), most commonly the toll-like receptors (TLR) (Lewis 2012 ) . Bacteria express pathogen-associated molecular patterns (PAMPs), which are unique to each microbial pathogen but share similar biochemical features. Alarmins are endogenous markers of tissue damage, and together constitute a larger family called damageassociated molecular patterns (DAMPs). Recognition of PAMPs and DAMPs results in release of pro-inflammatory cytokines, most notably NF-κ β , TNF-α , IL-1 and IL-6 (Bianchi 2007 ) . Anti-inflammatory cytokines including IL-10 are produced to maintain balance and to limit the inflammation to the site of infection. The pro-inflammatory and anti-inflammatory cascades operate simultaneously, but if the inflammatory stimulus persists, there can be down-regulation of innate immunity with apoptosis of immune cells, altered neutrophil function and dampening the response of PAMP recognition (Ward et al . 2008 ) . DAMPs promote intravascular thrombus formation through tissue factor expression on monocytes and limit bacterial dissemination (Ito et al . 2007 ) . If left uncontrolled immunothrombosis can lead to the development of disseminated intravascular coagulation (DIC), characterised by widespread microvascular thrombosis and depletion of coagulation factors and platelets (Pawlinski et al . 2004 ) and multiple organ dysfunction syndrome (MODS).
Recognition of bacteria or endotoxin and the resulting proinflammatory response directly affect intestinal motility and host microflora. Intestinal inflammation leads to hypomotility and BT through dysregulation of inducible nitric oxide synthase (iNOS) and neuronal NOS (nNOS) (Porras et al . 2008 ) . Maintenance of physiologic levels of nitric oxide (NO) by administration of a novel NO-donor can recover intestinal motility thus preventing bacteria overgrowth and BT (Porras et al . 2008 ) . Small intestinal bacterial overgrowth (SIBO) can result secondary to decreased gastric acid secretion, reduced intestinal motility and dysregulated mucosal and systemic immunity (Koutsounas et al . 2015 ) . This can be increased in severity in patients with concurrent liver disease because decreased hepatic clearance of microbial pathogens can lead to hepatocyte death, increased fibrosis and accumulation of inflammatory cells to potentiate systemic BT (Gunnarsdottir et al . 2003 , Brenchley & Douek 2012 .
Bacteria can propagate BT both directly and indirectly through induction of the systemic inflammatory response. While intestinal mucosal permeability can be directly affected by inflammatory mediators and ROS production, enteropathogenic bacteria produce enterotoxins that specifically target tight junction proteins of the GIT (Guttman & Finlay 2009 ). Host defences respond by increasing paracellular permeability to allow neutrophil migration across epithelial barriers. Barrier function is further compromised with TNF directly inducing enterocyte apoptosis, as well as phosphorylation of the myosin light chain of enterocytes, causing cytoskeleton rearrangement and modulation of tight junction protein expression (Shen 2012 ) . Transcellular transport of bacteria and endotoxin is mediated through lipid raft formation, which are membrane microdomains that are activated by receptor molecules (CD14, TLR4) following LPS stimulation (Triantafilou et al . 2002 ) . This allows passage of bacteria and endotoxin without disrupting tight junctions, in which pathogens invade epithelial cells, migrate across the cytoplasm and exit from the opposite surface (Taniguchi et al . 2016 ). Transcellular translocation was found to be reduced after removal of TLR4 and the lipid raft marker caveolin-1 (Chassin et al . 2008 ) . Once the epithelial barrier is breached, bacteria and endotoxin enter the systemic circulation and trigger a response by the innate immune system. Inflammation secondary to endogenous cytokine production has been linked to the pathogenesis of systemic inflammatory response syndrome (SIRS) and has been associated with poor outcomes (Gebhardt et al . 2009 , Yu et al . 2010 , Torrente et al . 2015 .
THERAPEUTIC TARGETS
Clinical management in attempt to minimise the negative outcome associated with BT involves the use of intravenous fluids and vasopressors to restore effective circulating volume and intestinal perfusion, institution of early enteral nutrition (EN) to preserve the normal GI flora and medications to support GI motility and to protect the GIT barrier function. The goal of the following information is to provide scientific background to assist clinicians in choosing therapies to limit the occurrence of BT and its effects. In-depth research and review articles are available for each of these therapeutic targets but this review is to serve as a basis for clinician-directed therapy.
Fluid therapy
The main goals in attempting to limit BT in critical illness include maintaining intestinal perfusion to limit IR injury and ensuring the continuity of the epithelial barrier and mucus layer. Intravenous crystalloids, colloids and vasopressors should be used to ensure an effective circulating volume and adequate end-organ perfusion (Cazzoli & Prittie 2015 ) . Judicious fluid administration should be performed to limit the gut wall (Shah et al . 2011 ). Goal-directed therapy has been shown to shorten post-operative ileus and reduce nausea and vomiting in humans following abdominal surgery (GomezIzquierdo et al . 2015 ) . Intravenous crystalloids can be administered for replacement of estimated blood volume (90 mL/kg dogs, 60 mL/kg cats) given in one-quarter increments with reassessment of perfusion parameters every 15 minutes (Driessen & Brainard 2006 ) . This can be supplemented with hypertonic solutions and synthetic colloids (7·5% hypertertonic saline 4 mL/kg, 6% hydroxyethyl starch 5 mL/kg) to minimise fluid extravasation into the interstitium (Hammond et al . 2014 ). The use of crystalloids versus colloids is controversial because human studies have shown a lack of superior outcome with the use of artificial colloids (Cazzoli & Prittie 2015 ) . Hetastarch has the potential to cause acute kidney injury, thought to be due to the accumulation of lysosomes in the proximal tubule from pinocytosis of the colloid particles, leading to tubular swelling and interstitial inflammation (Hayes et al . 2016 ) . Synthetic colloid use contributes to coagulopathy through decreased levels of von Willebrand factor (vWF) and Factor VIII (fVIII) and decreased expression/activation of platelet integrin α IIb β 3 (Smart et al . 2009 , Morris et al . 2016 . Fluid therapy should be continued until traditional end-points of resuscitation are achieved, including normalisation of heart rate, arterial blood pressure and urine output. Studies have shown additional markers such as lactate, base excess and central venous oxygen saturation (S cv O 2 ) can be used to detect and treat occult global tissue hypoxia (Prittie 2006 ) .
If resuscitation end-points are not met with intravenous fluid use alone, vasopressors can be used to increase arterial pressure and improve perfusion. There is debate regarding the ideal vasopressor in maintaining blood pressure while preserving blood flow to the GIT in critically ill patients. Vasopressin, a non-catecholamine neurohypophysial hormone, has been shown to shunt blood flow from the skin and GIT to the brain, liver and kidneys (Holt et al . 2011 ) . Catecholamines, such as norepinephrine, have been associated with elevated levels of intestinal fatty acid-binding protein (I-FABP), which has been shown to be a marker of bowel ischaemia (Piton et al . 2015 ) . Decreased splanchnic perfusion secondary to catecholamine use may exacerbate BT (Levy et al . 1997 ) . As the goal of fluid therapy is restoration of microcirculatory perfusion, vasopressor use in fluid-resistant hypotension should be used cautiously and following adequate fluid resuscitation.
Nutrition
Benefits of early EN include reduced intestinal permeability, reduced incidence of bacteraemia, attenuation of the acute phase response, improved immunological status and preservation of a positive energy balance (Mohr et al . 2003 ) . Early EN has been found to decrease LOH in critically-ill dogs by maintaining GIT barrier function and improved splanchnic blood flow (Liu et al . 2012 ) . EN can be performed via a nasoenteric tube in a minimally invasive fashion. Due to the small diameter of a nasoenteric tube, only liquid diets can be fed (Han 2004 ) . A more aggressive feeding regimen can be performed with an oesophagostomy or gastric tube, but both of these procedures require general anaesthesia.
There is debate as to the optimum diet to provide to minimise the risk of BT. Research has shown that the addition of glutamine, arginine and omega-3 fatty acids can augment intestinal barrier function and prevent BT (Dombrowsky et al . 2011 , Shu et al . 2014 . Glutamine, a conditionally-essential amino acid, is the preferred metabolic fuel for enterocytes, and a recent study showed the addition of dietary glutamine prevented increased intestinal permeability and BT in a rodent model of heat shock . Another study demonstrated that BT was reduced when a specific nutritional combination diet including high protein, L-leucine, fish oil and specific oligliosaccharides was administered to mice receiving chemotherapy (Faber et al . 2011 ) . The ideal diet would provide high protein, moderate fat restriction and mixed fibre to promote maintenance of the normal GIT flora and intestinal motility (Kerl & Johnson 2004 ). Short-chain fatty acids are the preferred fuel for colonic epithelium and are produced through the fermentation of nondigestible carbohydrates. Insoluble fibre protects the intestinal epithelium by promoting mucus production, stimulating epithelial cell growth and preserving the resident microflora (Simpson & Campbell 2015 ) . There is concern that the addition of the n3-polyunsaturated fatty acid α -linolenic acid to diets can exacerbate intestinal inflammation, but no adverse effects were noted in alterations of the faecal microbiome or BT (Zarepoor et al . 2014 ) . The animal ' s resting energy requirement (RER) can be calculated by the formula: RER=70 (BW kg ) 0·75 . Burger & Johnson ( 1991 ) demonstrated that the unique size in varying dog breeds made the use of a power function for metabolic body size challenging, and instead suggested the use of the formula [RER=30 (BW kg ) + 70), which is easier for practitioners to use. However, this can overestimate the nutrition requirements in animals weighing less than 3 kg or more than 25 kg (Chan & Freeman 2006 ) . Typically, one-third of the RER is administered over the first 24 hours and if enteral feeding is tolerated, the volume can be increased to supply 100% of the daily RER over the next 1-2 days (Michel & Higgins 2006 ) . A recent study found no difference when administering continuous versus intermittent (bolus) feeding via nasoenteric tubes in the percentage of prescribed nutrition delivered or the frequency of GI complications (Campbell et al . 2010 ).
Antibiotics and gastroprotectants
Selective digestive decontamination (SDD) involves the administration of topical non-absorbable and parenteral antibiotics to reduce pathologic Gram-negative bacteria in favour of commensal anaerobes (Francis et al . 2014 ) . SDD is believed to reduce the incidence of infection and improve mortality rates, but concern over selection for antibiotic resistance has limited its acceptance (Oostdijk et al . 2010 ) . Two recent meta-analyses regarding the use of SDD in human intensive care unit ( ICU) settings showed no difference in the prevalence of colonisation or infection of antibiotic-resistant bacteria. SDD was associated with low levels of antibiotic resistance but there was no difference in mortality rates between SDD and controls (Daneman et al . 2013 , Oost- Unterer et al . ( 2011 ) showed no improvement in disease severity indices, LOH or mortality rates in dogs administered ampicillin-clavulanate versus placebo. The use of antimicrobials had no effect on BT when compared with placebo. Antibiotic administration has also been shown to induce translocation from native commensal bacteria and promote an inflammatory response (Knoop et al . 2015 ) . Metronidazole is a nitroimidazole antibacterial and antiprotozoal compound routinely used in the treatment of giardiasis, anaerobic infections and inflammatory bowel disease (Evans et al . 2003 ) . Studies demonstrated reduced colonic bacterial numbers when it was administered either orally or parenterally (Dion et al . 1980 ) . When administered orally, metronidazole reduces intestinal inflammation through suppression of cellular immunity, although the exact mechanism of this action remains to be elucidated (Bijarnason et al . 1992 ) . Metronidazole should be used cautiously because a recent study showed a significant decrease in aerobic and anaerobic bacterial counts in the duodenum of healthy cats, with the emergence of Streptococcus and Corynebacterium , thereby altering the commensal flora (Johnston et al . 2000 ) .
The role of gastroprotectants in preventing BT is controversial. Histamine-2 receptor blockers (H2RB) and proton pump inhibitors (PPI) such as 0·5 mg/kg famotidine intravenously (iv)/orallytwice daily and 0·5 mg/kg omeprazole orally once a day raise gastric pH (Bersenas et al . 2005 ) . Proton pump inhibitors are proven to be more effective at raising intragastric pH than H2RB (Tolbert et al . 2010 ) . Injectable 1 mg/kg pantoprazole iv once a day, a benzimidazole PPI, used alone is as effective at increasing intragastric pH as combination therapy of pantoprazole with famotidine (Tolbert et al . 2015 ) . These medications are often used as empirical therapy for vomiting, gastroduodenitis, esophagitis or for prevention of gastric ulceration, but are thought to be causing more harm than good ( Parente et al . 2014) . High gastric pH may allow for colonisation of the upper GIT with Gram-negative bacteria (Litton et al . 2014 ) . A recent human meta-analysis comparing H2RB (ranitidine and cimetidine) versus sucralfate showed higher rates of gastric colonisation and ventilator-associated pneumonia with H2RB (Huang et al . 2010 ) . Proton pump inhibitorinduced dysbiosis is considered a type of small intestinal bacterial overgrowth in humans (Fujimori 2015 ) .
Sucralfate, a cytoprotective agent, provides gastric and duodenal protection through formation of an insoluble surface layer, preventing back-diffusion of hydrogen ions, inactivating pepsin and absorbing gastric-damaging BA (Henderson & Webster 2006 ) . A dose of 0·5 to 1 g sucralfate orally three times a day stimulates prostaglandins and growth factors which enhance mucosal blood flow and increase secretion of mucus and bicarbonate. Sucralfate inhibits BT by preserving intestinal barrier function and limits BT to the MLN and pancreas compared with controls in an experimental model of pancreatitis (Colak et al . 2001 ) . Akman et al . ( 2000 ) demonstrated no significant difference in the incidence of BT between study groups including sucralfate versus gentamicin and sucralfate combined with gentamicin in mice. The author therefore postulated that sucralfate was superior to SDD due to preservation of the commensal microflora.
Gastrointestinal motility and additional therapies Metoclopramide, a central antiemetic and prokinetic, functions through agonism of the 5-hydroxytryptamine receptor (5HT 4 ) and promotes gastric emptying in veterinary patients (Woosley 2004 ) . Gastroparesis predisposes patients to duodenogastric and gastro-oesophageal reflux, which have been associated with an increased incidence of BT (Deane et al . 2009 ). Metoclopramide (1 to 2 mg/kg/day, 0·2 to 0·4 orally/subcutaneously three times a day) increases the resting tone of the gastro-oesophageal sphincter in dogs, thus decreasing the risk of gastro-oesophageal reflux with negligible haemodynamic effects even at higher doses (1 mg/ kg/hour) than previously reported (Wilson et al . 2006 ) .
Cisapride is a more potent 5HT 4 receptor antagonist than metoclopramide with strong prokinetic effects (Zacuto et al . 2012 ) . The mechanism of action is thought to be increased acetylcholine release at the myenteric plexus to promote intestinal motility (Kempf et al . 2014 ) . Cisapride is associated with decreased intestinal transit time and improved intestinal permeability to limit bacterial overgrowth and BT (Pardo et al . 2000 , Zhang et al . 2003 .
Erythromycin, a macrolide antibiotic, can increase gastric motility by acting on motilin receptors in smooth muscle cells of the stomach (Woosley 2004 ) . Human studies have shown erythromycin can help prevent delayed gastric emptying associated with general anaesthesia and decreases acidity and residual gastric fluid volume (Czarnetzki et al . 2015 ) . Erythromycin administered at low doses (0·5 to 1 mg/kg three times a day) is not associated with antimicrobial effects (Boothe 2012 ) . Future avenues of research may include the use of probiotics and prebiotics. Probiotics are live microorganisms that, when consumed in adequate amounts, confer a health effect on the host by direct inhibition of colonisation by pathogenic microorganisms and by immuneenhancing effects on GALT (Bybee et al . 2011 ) . Studies in veterinary medicine have yet to consistently demonstrate a benefit to probiotic administration, but no detrimental effects have been noted (Schmitz et al . 2015 ) . Prebiotics are fermentable fibres that lead to specific changes in the composition and activity of gut microbiota to the benefit of the host (Zaman et al . 2015 ) . Similar to veterinary studies on probiotics, inconsistent results were seen in the isolation of beneficial genera such as Bifidobacterium and Lactobacillus and no effect was noted on Clostridium or E . coli (Willard et al . 2000 ) . A more recent study demonstrated the positive effect of prebiotic use in cats (Biagi et al . 2013 ) . Synbiotics refer to nutritional supplements combining probiotics and prebiotics for a synergistic effect (Serban 2015 ) . Human studies document lower intestinal permeability and infectious complications with the use of prebiotics, probiotics and synbiotics (Spindler-Vesel et al . 2007 , Giamarellos-Bourboulis et al . 2009 ).
CONCLUSION
BT has been associated with an increased prevalence of septic complications in critically-ill people, but this remains to be elucidated in veterinary studies. While BT in veterinary patients has been documented, its role in critical illness and the development of SIRS and MODS has yet to be established. Further studies are warranted to document the presence of BT and whether these patients are at an increased risk for septic complications. Despite an uncertain clinical significance in veterinary patients, steps can be taken to minimise potential negative effects of BT. Judicious use of antimicrobials or SDD may be considered in certain patient populations at high risk of BT. Sucralfate may be superior to other gastroprotectant medications in maintaining intestinal barrier function and preservation of the commensal microflora, while providing early EN and prokinetic medications further enhance intestinal barrier function and limit bacterial adherence.
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